Sign In
Buy PPH
$101.22
-1.06 (-1.04%)
At Close: Jun 02, 2026
PPH: Unnecessary Volatility In A Relatively Stable Healthcare Sector (Technical Analysis)
02:46pm, Monday, 17'th Jul 2023
Pharmaceutical ETFs like PPH may introduce another layer of risk that could be avoided if one took a broader approach to healthcare investing. Technical Analysis displays that beneath the most recent
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:38am, Thursday, 29'th Jun 2023
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.
ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics
01:19pm, Wednesday, 21'st Jun 2023
Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lilly's efforts to bolster its immunology pipeline, s
How the Pharmaceutical Industry Is Using AI
11:38am, Saturday, 13'th May 2023
Industry-leading pharmaceutical firms are adopting artificial intelligence (AI) to drive value for the future of their enterprise. AI is currently being implemented within the industry to reduce human
Pharma ETFs Gain Post Q1 Earnings
01:01pm, Tuesday, 09'th May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:37am, Monday, 24'th Apr 2023
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market
ETFs to Buy on Solid Q1 JNJ Earnings Results
12:56pm, Wednesday, 19'th Apr 2023
Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.
PPH Fell As Much As The Market Despite Resilience
03:49pm, Friday, 24'th Mar 2023
The US market is highly speculative right now, as it's bid up to levels comparable to before stresses in the banking system had been revealed by SVB Financial. PPH, which follows a broad basket of the
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:32am, Tuesday, 21'st Feb 2023
Sector ETF report for PPH
Betting On Biotech
10:02am, Friday, 10'th Feb 2023
Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow. Passive investors seeking a defensive position might just pu
PPH Might Be Too Safe For A Recovering Market
05:28pm, Friday, 13'th Jan 2023
We think that the bear market is coming to an end, as it must. The way to go is to invest in higher beta, or at least in more beaten down issues.
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Best ETFs Try To Emerge For A Better 2023 For Investors
07:00am, Friday, 06'th Jan 2023
Stocks closed off a tumultuous year on a sour note in December. What's next for best ETFs?
Growth, Innovation Could Fuel Pharma ETF Rebound
12:31pm, Wednesday, 21'st Dec 2022
For much of 2020 and 2021, the pharmaceutical stock investment thesis revolved around development and disbursement of coronavirus vaccines. While that made for an obvious catalyst, and a rewarding one
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
07:31am, Tuesday, 20'th Dec 2022
Sector ETF report for PPH
